Evonik, a specialty chemicals company, is moving its North American headquarters from Parsippany, N.J., to Piscataway, N.J. The official address change took effect on January 1, 2023. The Parsippany location will be closed with the end of its lease later this year.
Ensuring Efficient Operations & Future Growth
The relocation is part of Evonik’s larger site rationalization plan to ensure efficient operations and future growth in North America. Evonik has embraced a hybrid work model in the region to consolidate office space, enhance employee engagement, and increase employer attractiveness.
“
For Evonik, moving towards a hybrid workplace is a strategic opportunity to attract and retain diverse talent and to enable an efficient real estate footprint,” said Bonnie Tully, president North America region. “
We want to foster conditions for growth, creativity, and innovation.”
The new Piscataway headquarters, located approximately 35 miles southwest of New York City, consists of administrative offices, laboratories for Research & Development, and the largest Collaboration Hub in the North America region, designed to support a hybrid and creative work environment for more than 160 employees.
Evonik has recently opened similar hubs at its sites in Richmond, Va., and Mobile, Ala., and will eventually feature them at six locations in North America.
Supporting Hybrid Work Environment with Collaboration Hubs
The uniquely designed spaces offer open areas and meeting rooms for employees to work onsite without needing individual offices. Employees have access to collaboration technology like digital whiteboards and tools for video conferencing.
"
The Collaboration Hubs promote interactions across our business lines and functions," added Tully. "
It will shape the future of work at Evonik and contribute to our culture of innovation."
North America is an essential growth market for Evonik. The region contributed roughly a quarter (23%) to Evonik's annual sales in 2021, making it the second-largest revenue source after Europe (EMEA).
Source: Evonik